Practical Geriatrics ›› 2025, Vol. 39 ›› Issue (8): 832-836.doi: 10.3969/j.issn.1003-9198.2025.08.016
Previous Articles Next Articles
HE Zijun, GUO Xiangsheng, LI Zhenyong, LI Zhigang, LU Wen
Received:
2024-12-10
Online:
2025-08-20
Published:
2025-08-19
Contact:
LU Wen, Email:lzr357@163.com
CLC Number:
HE Zijun, GUO Xiangsheng, LI Zhenyong, LI Zhigang, LU Wen. Correlation between body mass index and vasospastic angina in elderly patients with hypertension[J]. Practical Geriatrics, 2025, 39(8): 832-836.
[1] MATTA A, BOUISSET F, LHERMUSIER T, et al. Coronary artery spasm: new insights[J]. J Interv Cardiol, 2020, 2020: 5894586. [2] KOOK H, HONG S J, YANG K S, et al. Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: a prospective, randomized, double-blind pilot study[J]. PLoS One, 2020, 15(9): e0239039. [3] HELD C, HADZIOSMANOVIC N, AYLWARD P E, et al. Body mass index and association with cardiovascular outcomes in patients with stable coronary heart disease: a STABILITY substudy[J]. J Am Heart Assoc, 2022, 11(3): e023667. [4] WADE K H, CHIESA S T, HUGHES A D, et al. Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses[J]. Circulation, 2018, 138(20): 2187-2201. [5] OHYAMA K, MATSUMOTO Y, SHIMOKAWA H. Coronary artery spasm and perivascular adipose tissue inflammation: insights from translational imaging research[J]. Eur Cardiol, 2019, 14(1): 6-9. [6] LEE M H, JO S H, KWON S, et al. Impact of overweight/obesity on clinical outcomes of patient with vasospastic angina: from the vasospastic angina in Korea registry[J]. Sci Rep, 2020, 10(1): 4954. [7] BELTRAME J F, CREA F, KASKI J C, et al. International standardization of diagnostic criteria for vasospastic angina[J].Eur Heart J, 2017, 38(33):2565-2568. [8] DORBALA S, ANANTHASUBRAMANIAM K, ARMSTRONG I S, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation[J]. J Nucl Cardiol, 2018, 25(5): 1784-1846. [9] 鹿存芝, 骆秉铨, 王亚楠, 等. 核素TID比值诊断非梗阻性冠心病心肌缺血[J]. 标记免疫分析与临床, 2021, 28(2): 243-245, 250. [10] POWELL-WILEY T M, POIRIER P, BURKE L E, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association[J]. Circulation, 2021, 143(21): e984-e1010. [11] GILL D, ZUBER V, DAWSON J, et al. Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis[J]. Int J Obes, 2021, 45(7): 1428-1438. [12] LUO H, LIU Y, TIAN X, et al. Association of obesity with cardiovascular disease in the absence of traditional risk factors[J]. Int J Obes, 2024, 48(2): 263-270. [13] DUDINA A, COONEY M T, DE BACQUER D, et al. Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators[J]. Eur J Cardiovasc Prev Rehabil, 2011, 18(5): 731-742. [14] PARTO P, LAVIE C J. Obesity and cardiovascular diseases[J]. Curr Probl Cardiol, 2017, 42(11): 376-394. [15] QUERCIOLI A, PATAKY Z, VINCENTI G, et al. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity[J]. Eur Heart J, 2011, 32(11): 1369-1378. [16] TONA F, SERRA R, DI ASCENZO L, et al. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease[J]. Nutr Metab Cardiovasc Dis, 2014, 24(4): 447-453. [17] VAN DER HEIJDEN D J, VAN LEEUWEN M A H, JANSSENS G N, et al. Body mass index is associated with microvascular endothelial dysfunction in patients with treated metabolic risk factors and suspected coronary artery disease[J]. J Am Heart Assoc, 2017, 6(9): e006082. [18] WANG Z J, ZHOU Y J, GALPER B Z, et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis[J]. Heart, 2015, 101(20): 1631-1638. [19] HAIDAR A, HORWICH T. Obesity, cardiorespiratory fitness, and cardiovascular disease[J]. Curr Cardiol Rep, 2023, 25(11): 1565-1571. [20] CORNEJO M A, ORTIZ R M. Body mass cycling and predictors of body mass regain and its impact on cardiometabolic health[J]. Metabolism, 2021, 125: 154912. [21] ALMUWAQQAT Z, HUI Q, LIU C, et al. Long-term body mass index variability and adverse cardiovascular outcomes[J]. JAMA Netw Open, 2024, 7(3): e243062. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|